Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 101-150 of 1147 result(s).
CYDY CytoDyn Inc
05/29/2025 3:03:38 PM
Table of Surrogate Endpoints That W (6)
CYDY CytoDyn Inc
05/28/2025 12:14:55 AM
March letter --- "As we approach ke (5)
CYDY CytoDyn Inc
05/26/2025 2:07:59 PM
When Cytodyn said: CytoDyn Announce (5)
CYDY CytoDyn Inc
05/26/2025 11:35:38 AM
TMZ is a chemo. Hoping we've now ra (7)
CYDY CytoDyn Inc
05/26/2025 11:15:34 AM
Aug. 25th, 2021 & PD-L1: The non-ra (7)
CYDY CytoDyn Inc
05/26/2025 1:11:51 AM
Temozolomide is the only FDA-approv (4)
CYDY CytoDyn Inc
05/25/2025 5:44:54 PM
The very last comment in our video, (3)
CYDY CytoDyn Inc
05/25/2025 12:34:58 PM
Four out of 100. That is the surviv (1)
CYDY CytoDyn Inc
05/25/2025 8:41:52 AM
*Einstein has publication decision (2)
CYDY CytoDyn Inc
05/25/2025 8:14:52 AM
TMZ / Glio is identical situation t (3)
CYDY CytoDyn Inc
05/25/2025 2:11:22 AM
Humanized mouse blood vessel data - (7)
CYDY CytoDyn Inc
05/24/2025 11:54:45 PM
The AAV Vector patent mentions BBB (2)
CYDY CytoDyn Inc
05/24/2025 11:33:09 PM
The prolongation of TMZ treatment f (7)
CYDY CytoDyn Inc
05/24/2025 1:43:51 PM
Of course agree 100%. Just wish som (3)
CYDY CytoDyn Inc
05/24/2025 1:33:18 PM
Some types of solid tumors occur on (3)
CYDY CytoDyn Inc
05/24/2025 1:18:34 PM
Nobody knows the 5/5 yet...or # of (1)
CYDY CytoDyn Inc
05/24/2025 12:50:04 PM
Acinetobacter baumannii during covi (1)
CYDY CytoDyn Inc
05/24/2025 11:51:15 AM
Patient #4 HER2+ re-post: Prior to (10)
CYDY CytoDyn Inc
05/23/2025 12:21:40 PM
In one embodiment, the administrat (4)
CYDY CytoDyn Inc
05/22/2025 10:18:26 PM
Haha....& i just said on ST: 5 yr.. (2)
CYDY CytoDyn Inc
05/22/2025 9:30:40 PM
& look @ his vesting period 1st 250 (1)
CYDY CytoDyn Inc
05/22/2025 9:21:50 PM
Basket trial: CTCs secondary end po (1)
CYDY CytoDyn Inc
05/22/2025 2:36:06 AM
Like i've pointed out a patent dose (7)
CYDY CytoDyn Inc
05/20/2025 4:42:30 PM
LL has cleared metastatic prostate (2)
CYDY CytoDyn Inc
05/20/2025 1:44:08 PM
They're crossed misiu --- been 1 he (6)
CYDY CytoDyn Inc
05/20/2025 12:56:35 PM
2021: Outcome Measures: Correlation (1)
CYDY CytoDyn Inc
05/20/2025 12:21:25 PM
Measuring PD-L1 was a trial Measure (5)
CYDY CytoDyn Inc
05/19/2025 5:10:22 PM
Thx KC & mfg --- question: how do y (1)
CYDY CytoDyn Inc
05/19/2025 10:34:19 AM
Yes, the FDA has accepted PD-L1 as (15)
CYDY CytoDyn Inc
05/19/2025 5:38:42 AM
Looking it over from Feb. 11th -- n
CYDY CytoDyn Inc
05/19/2025 5:18:20 AM
Wooo...just found the post -- but w
CYDY CytoDyn Inc
05/19/2025 4:22:56 AM
Hahaa...just that NASDAQ can be put
CYDY CytoDyn Inc
05/19/2025 4:15:06 AM
If there's any drug to break the mo
CYDY CytoDyn Inc
05/19/2025 4:09:14 AM
Would like to see FDA path, state/f (2)
CYDY CytoDyn Inc
05/19/2025 3:51:16 AM
Someone posted inbetween this they (2)
CYDY CytoDyn Inc
05/19/2025 3:41:37 AM
Agree 100%. Have said the same sinc (2)
CYDY CytoDyn Inc
05/19/2025 12:59:29 AM
sherlock -- don't forget Long actin (2)
CYDY CytoDyn Inc
05/19/2025 12:17:56 AM
Inflammation "CCR5" mixed with a lo (1)
CYDY CytoDyn Inc
05/18/2025 11:18:33 PM
Yea...LL won't patent extend Keytru (3)
CYDY CytoDyn Inc
05/18/2025 10:42:14 PM
They'll switch to the LL side & wor (2)
CYDY CytoDyn Inc
05/18/2025 10:31:18 PM
Targeting PD-1/PD-L1, either alone (3)
CYDY CytoDyn Inc
05/18/2025 7:23:00 PM
Leronlimab goes out into the dark, (1)
CYDY CytoDyn Inc
05/18/2025 12:08:25 PM
Need clarity this week on where we (3)
CYDY CytoDyn Inc
05/18/2025 8:04:57 AM
Maybe this FDA table for surrogate (2)
CYDY CytoDyn Inc
05/18/2025 12:14:58 AM
Study: Long COVID ‘brain fog’ l (3)
CYDY CytoDyn Inc
05/17/2025 10:31:42 PM
Commissioner Makary continues to gi (3)
CYDY CytoDyn Inc
05/17/2025 7:34:08 PM
Accelerated approval. FDA may grant (12)
CYDY CytoDyn Inc
05/17/2025 7:31:31 PM
KC -- here's Tracies patent & when (1)
CYDY CytoDyn Inc
05/17/2025 6:37:17 PM
Nope...a much higher dosing is refe
CYDY CytoDyn Inc
05/17/2025 5:35:20 PM
Forgot to add on the CFO: "....with (1)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Class Action Update for Sarepta Therapeutics Investors
  • Purpose Investments Inc. Unveils New Distribution Schedule 2025
  • Amazing Growth of HCA Healthcare Revealed Over a Decade
  • PepGen Inc. Faces Class Action: Investor Counsel Alert
  • The Growth Journey of a $100 HubSpot Investment Over Five Years
  • Investors Should Stay Alert: Petco Class Action Insights
  • Celebrating Excellence: Robert Michael & Co.'s Real Estate Triumph
  • Tam Fortis Innovations in Nuclear Power Solutions for Tomorrow
  • Syria's Sanction Lift: A New Chapter in Economic Progress
  • Robert Michael & Co.: Celebrating Success and New Listings
  • Unlocking the Growth Potential of Primerica Stock Investment
  • Understanding Market Recovery: Factors Behind Wall Street's Surge
  • Projected Growth of S&P 500: The Path to 6,500 by 2025
  • BigBear.ai: A Compelling Opportunity for Investors
  • Vitality Products Reports Impressive Growth in Q1 Metrics
  • Experience Singapore's Rich Heritage at Grand Park City Hall
  • Volatus Aerospace Embraces Canada's Defense Spending Commitment
  • Examining the Merger and Class Action Against GNTY
  • How $100 in Vertex Pharmaceuticals Grew Over a Decade
  • Giant Eagle's Strategic Move: Selling GetGo to Couche-Tard
  • OLIVE TREE PEOPLE Expands Waterless Beauty into Canada Soon
  • Bombardier Receives $1.7 Billion Order for 50 Aircraft
  • COSCIENS Biopharma's Shareholder Meeting Outcomes and Updates
  • Investing in Teledyne Technologies: A 15-Year Journey Unveiled
  • Bombardier Secures Major Order for 50 Challenger and Global Jets
  • Krispy Kreme Investors Alert: Class Action Lawsuit Filed
  • Neuberger Berman Fund Declares Monthly Distribution Plan
  • Pet King Brands Celebrates Vanguard Award for ZYMOX Innovation
  • Legal Action Explores Fairness of Turnstone Biologics Merger
  • Exploring Charles Schwab's Exceptional Growth Over Time
  • Argo Corporation Shares Key Decisions Post Shareholder Meeting
  • Neuberger Berman High Yield Strategies Fund Updates Shareholders
  • Investigation into Designer Brands Inc. Sparks Legal Response
  • American Tungsten Corp. Moves Forward with Private Placement
  • Sulliden Mining Capital's Annual Meeting Results Unveiled
  • B2Gold Celebrates Inaugural Gold Pour at Goose Mine Milestone
  • Estimating the Costs of Cookouts in the Coming Years
  • Transforming $100 into Over $2,000: A Stock Journey
  • Celebrating Reddit's 20 Years: Surprising Facts Unveiled
  • Understanding Parker Hannifin's P/E Ratio: A Deep Dive
  • Neuberger Berman High Yield Strategies Fund Announces New Distribution Policy
  • Neuberger Berman Fund Declares Monthly Distribution in 2025
  • Neuberger Berman Real Estate Fund Declares New Monthly Dividend
  • Neuberger Berman Fund Declares Monthly Cash Distribution for Investors
  • Neuberger Berman Announces New Monthly Distribution Update
  • Neuberger Berman Next Generation Connectivity Fund Updates & Rating
  • Susie White Honored with Prestigious SBCMS President's Award
  • Silicon Motion Welcomes Jeffrey Ju as New Senior VP of Strategy
  • Community Celebrates Geronimo Power's Impactful Solar Project
  • Exploring the Future of Cryptocurrency with DEAL Mining
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site